AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Sep 3, 2014
30016_dirs_2014-09-03_674db87b-e82c-4a04-969b-691835336430.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-09-01
Reporting Person: MAZELSKY JAY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-01 | Common Stock | M | 1184 | — | Acquired | 2378 | Direct |
| 2014-09-01 | Common Stock | F | 383 | $123.9700 | Disposed | 1995 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-01 | Restricted Stock Unit | $ | M | 1184 | Disposed | Common Stock (1184) | Direct |
Footnotes
F1: Includes 59 shares and 49 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/31/2014 and 06/30/2014, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (09/01/2013) of the date of grant.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26